| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/18/2011 | CA2420130C Composition for aqueous stabilization of fat-soluble vitamins |
| 01/18/2011 | CA2408008C Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 01/18/2011 | CA2401089C Anaesthetic formulations |
| 01/18/2011 | CA2377402C Silver-containing, sol-gel derived bioglass compositions |
| 01/18/2011 | CA2368637C Topical treatment or prevention of ocular infections |
| 01/18/2011 | CA2284399C Use of magnesium (mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 01/18/2011 | CA2269895C Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract |
| 01/14/2011 | CA2709589A1 Civamide patch for localized post-incisional neuropathic pain |
| 01/13/2011 | WO2011006079A2 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 01/13/2011 | WO2011006029A1 Artificial cell constructs for inducing immunological tolerance |
| 01/13/2011 | WO2011005853A2 Compositions and methods of topical drug delivery for the treatment of carpal tunnel syndrome |
| 01/13/2011 | WO2011005841A1 Sodium thiosulfate-containing pharmaceutical compositions |
| 01/13/2011 | WO2011005772A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | WO2011005720A1 Method of drug delivery |
| 01/13/2011 | WO2011005714A2 Bendamustine liposomal compositions |
| 01/13/2011 | WO2011005686A1 Self-breaking tablets |
| 01/13/2011 | WO2011005646A2 Pharmaceutical composition for a hepatitis c viral protease inhibitor |
| 01/13/2011 | WO2011005478A2 Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen |
| 01/13/2011 | WO2011005381A2 Vortex-induced silk fibroin gelation for encapsulation and delivery |
| 01/13/2011 | WO2011005352A1 Sustained-release drug delivery compositions and methods |
| 01/13/2011 | WO2011005250A1 Formulations of 6- (5-chloro-2-pyridyl) - 5- [ (4-methyl-1-piperazinyl) carbonyloxy] - 7-0x0-6, 7- dihydro- 5h- phyrrolo [3, 4-b] pyrazine |
| 01/13/2011 | WO2011005113A1 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
| 01/13/2011 | WO2011004799A1 Tablet having hollow structure |
| 01/13/2011 | WO2011004552A1 Water-soluble drug carrier and process for production thereof |
| 01/13/2011 | WO2011004395A1 Microemulsion formulation for biologicals |
| 01/13/2011 | WO2011004376A1 Matrix carrier compositions, methods and uses |
| 01/13/2011 | WO2011004328A2 Crosslinked protein nanocrystals, crosslinked protein nanoaggregates and method of preparation thereof |
| 01/13/2011 | WO2011004293A1 Method for preparing polymerized lipid constructs, resulting polymerized lipid constructs, and uses thereof for encapsulating active agents |
| 01/13/2011 | WO2011004175A2 Viscous topical antimicrobial compositions |
| 01/13/2011 | WO2011004158A1 Solubilisation of membrane proteins |
| 01/13/2011 | WO2011004126A1 Substrate impregnated with sprayed clay, and method for manufacturing same |
| 01/13/2011 | WO2011004117A1 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes |
| 01/13/2011 | WO2011003853A2 Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient |
| 01/13/2011 | WO2011003834A1 Amphoteric liposomes comprising imino lipids |
| 01/13/2011 | WO2011003822A2 Insulin preparations containing methionine |
| 01/13/2011 | WO2011003820A1 Heat- and vibration-stable insulin preparations |
| 01/13/2011 | WO2011003766A1 Biodegradable copolymer comprising amylopectin or glycogen suitable for delivering nucleic acid materials into cells |
| 01/13/2011 | WO2011003603A2 Composition for the production of tablets, and method for the production of said composition |
| 01/13/2011 | WO2011003602A2 Tableting agent having a low water content, and method for the production thereof |
| 01/13/2011 | WO2011003362A1 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof |
| 01/13/2011 | WO2011003226A1 Pharmaceutical composition for treating depression and preparative method and use thereof |
| 01/13/2011 | WO2011003221A1 A medicine composition for treating bronchial asthma and preparative method thereof |
| 01/13/2011 | WO2010133374A3 Therapeutic composition comprising microspheres |
| 01/13/2011 | WO2010132047A8 Guanosine/gmp gels and uses thereof |
| 01/13/2011 | WO2010128525A3 A formulation of ivabradine for treating the cardiovascular disease |
| 01/13/2011 | WO2010128504A3 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery |
| 01/13/2011 | WO2010128486A3 Ophthalmic formulation for the treatment and prevention of pterygium |
| 01/13/2011 | WO2010120389A3 Polymeric drug delivery systems and processes for producing such systems |
| 01/13/2011 | WO2010119041A3 Method of producing microbeads |
| 01/13/2011 | WO2010117419A3 Method of determining body exit of an ingested capsule |
| 01/13/2011 | WO2010115013A3 Functionalized fullerenes as antifungal agents |
| 01/13/2011 | WO2010112762A4 Functionalized pharmaceutical carrier improving the bioavailability of active substances having a very low solubility, and microgranules containing same |
| 01/13/2011 | WO2010107794A3 Compositions and methods for delivering an agent to a wound |
| 01/13/2011 | WO2010099542A3 Formulations of atp and analogas of atp |
| 01/13/2011 | WO2010099510A3 Amino acid-based compounds, their methods of use, and methods of screening |
| 01/13/2011 | WO2010089105A3 Moisture-activated granulation process |
| 01/13/2011 | WO2010081824A3 Active coating of pharmaceutical dosage forms |
| 01/13/2011 | WO2010079052A3 Nanoparticle compositions |
| 01/13/2011 | WO2010078935A3 Solutions for volume therapy |
| 01/13/2011 | WO2010075298A3 An implantable composite comprising a tacky biocompatible polymer film and a releasable bioactive agent |
| 01/13/2011 | WO2010021973A3 Controlled delivery of bioactive agents from decomposable films |
| 01/13/2011 | WO2010003268A3 Methods and compositions for enhanced delivery of macromolecules |
| 01/13/2011 | WO2009153634A8 A transmucosal delivery system |
| 01/13/2011 | WO2009099831A3 Edible film-strips with modified release active ingredients |
| 01/13/2011 | WO2009061482A3 Anesthetic composition, formulation and method of use |
| 01/13/2011 | US20110009955 Compounds and method for coating surfaces in a hemocompatible manner |
| 01/13/2011 | US20110009570 Preparation of polyphosphazene microspheres |
| 01/13/2011 | US20110009321 Nasal calcitonin formulations containing chlorobutanol |
| 01/13/2011 | US20110008543 Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 01/13/2011 | US20110008527 Solid Medication Tracking |
| 01/13/2011 | US20110008526 Multi-layered coatings and methods for controlling elution of active agents |
| 01/13/2011 | US20110008456 Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| 01/13/2011 | US20110008455 Crosslinked Protein Nanocrystals, Crosslinked Protein Nanoaggregates and Method of Preparation Thereof |
| 01/13/2011 | US20110008454 Immediate release pharmaceutical granule compositions and a continuous process for making them |
| 01/13/2011 | US20110008453 Stable Corticosteroid Nanoparticulate Formulations And Methods For The Making And Use Thereof |
| 01/13/2011 | US20110008452 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| 01/13/2011 | US20110008451 Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| 01/13/2011 | US20110008450 Slow Release Compositions |
| 01/13/2011 | US20110008449 Human Specific Escherichia Coli Strains |
| 01/13/2011 | US20110008448 Diketopiperazine Salts for Drug Delivery and Related Methods |
| 01/13/2011 | US20110008447 Carrier comprising nanodiamond |
| 01/13/2011 | US20110008446 Method of Drug Delivery |
| 01/13/2011 | US20110008445 Suspension of ascorbic acid in glycerin and process for production thereof |
| 01/13/2011 | US20110008444 Composition for the formation of gels |
| 01/13/2011 | US20110008443 Photocrosslinked biodegradable hydrogel |
| 01/13/2011 | US20110008442 Dendritic Macroporous Hydrogels Prepared by Crystal Templating |
| 01/13/2011 | US20110008441 Thermoresponsive arginine-based hydrogels as biologic carriers |
| 01/13/2011 | US20110008440 Novel nanocompound materials with infrared, ultraviolet and visible electromagnetic radiation blocking properties and method for obtaining them |
| 01/13/2011 | US20110008439 Duloxetin composition |
| 01/13/2011 | US20110008438 Bone Repair Composition and a Method of Making the Same |
| 01/13/2011 | US20110008437 Silk Fibroin Hydrogels and Uses Thereof |
| 01/13/2011 | US20110008436 Silk Fibroin Hydrogels and Uses Thereof |
| 01/13/2011 | US20110008435 Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic Compounds |
| 01/13/2011 | US20110008434 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 01/13/2011 | US20110008433 Herbal Composition for Osteoarthritis |
| 01/13/2011 | US20110008432 Method for Treating a Patient in Need of Aspirin Therapy |
| 01/13/2011 | US20110008431 Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia |
| 01/13/2011 | US20110008430 Solid Pharmaceutical Dosage Form |
| 01/13/2011 | US20110008429 Anti-Retroviral Combination |
| 01/13/2011 | US20110008428 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |